Natural Product: NPC510837

Natural Product IDNPC510837
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
[(2~{S},3~{S},4~{S},5~{R},6~{S})-3,4,5-trihydroxy-6-[3-(4-methoxyphenyl)-4-oxo-chromen-7-yl]oxy-tetrahydropyran-2-yl]methyl acetate
IUPAC Name [(2~{S},3~{S},4~{S},5~{R},6~{S})-3,4,5-trihydroxy-6-[3-(4-methoxyphenyl)-4-oxo-chromen-7-yl]oxy-tetrahydropyran-2-yl]methyl acetate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HZJBDSMAAFNHHL-LKAHAZCJSA-N
Standard InCHI InChI=1S/C24H24O10/c1-12(25)31-11-19-21(27)22(28)23(29)24(34-19)33-15-7-8-16-18(9-15)32-10-17(20(16)26)13-3-5-14(30-2)6-4-13/h3-10,19,21-24,27-29H,11H2,1-2H3/t19-,21+,22-,23+,24+/m0/s1
SMILES COC1=CC=C(C2=COC3=CC(O[C@@H]4O[C@@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]4O)=CC=C3C2=O)C=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   472.14 Volume:   453.608
?
Van der Waals volume.
Dense:   1.041 LogP:   1.072
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.572
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.4
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   25.0
TPSA:   144.89
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   3.0 Rings:   4.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.448 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.687 Fsp3:   0.333
MCE-18:   82.812
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.573 Fluc inhibitor:   0.651
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.915
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.772
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.058 Promiscuous compounds:   0.139

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.844 MDCK Permeability:   -5.077
Pgp-inhibitor:   0.043 Pgp-substrate:   0.281
PAMPA:   0.971
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.821
20% Bioavailability (F20%):   0.372 30% Bioavailability (F30%):   0.913
50% Bioavailability (F50%):   0.926

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.212
Plasma Protein Binding (PPB):   88.095% Volume Distribution (VD):   -0.47
Fu: 10.703%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.998
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.12
BSEP inhibitor:   0.641

ADMET: Metabolism

CYP1A2-inhibitor:   0.855 CYP1A2-substrate:   0.045
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.025 CYP2C9-substrate:   0.03
CYP2D6-inhibitor:   0.001 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.918
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.002
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.478 Half-life (T1/2):  2.052

ADMET: Toxicity

hERG Blockers:  0.102 hERG Blockers (10um):  0.332
Human Hepatotoxicity (H-HT):  0.615 Drug-induced Liver Injury (DILI):  0.981
AMES Toxicity:  0.924 Rat Oral Acute Toxicity:  0.107
Maximum Recommended Daily Dose:  0.055 Skin Sensitization:  0.81
Carcinogencity:  0.477 Eye Corrosion:  0.0
Eye Irritation:  0.363 Respiratory Toxicity:  0.02
Drug-induced Neurotoxicity:  0.07 Ototoxicity:  0.758
Hematotoxicity:  0.334 Drug-induced Nephrotoxicity:  0.845
Genotoxicity:  0.809 RPMI-8226 Immunitoxicity:  0.111
A549 Cytotoxicity:  0.092 Hek293 Cytotoxicity:  0.12
BCF:   0.622
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.385
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.828
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.313
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21579 Ononis speciosa Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[8277313]
NPO21579 Ononis speciosa Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO21579 Ononis speciosa Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC510837 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7792 Intermediate Similarity NPC43761
0.7703 Intermediate Similarity NPC45165
0.7534 Intermediate Similarity NPC25547
0.7011 Intermediate Similarity NPC51326
0.6778 Remote Similarity NPC235575
0.6709 Remote Similarity NPC211014
0.6667 Remote Similarity NPC231194
0.6506 Remote Similarity NPC229729
0.642 Remote Similarity NPC161749
0.6375 Remote Similarity NPC135345
0.6364 Remote Similarity NPC475155
0.625 Remote Similarity NPC487214
0.6118 Remote Similarity NPC601607
0.5972 Remote Similarity NPC136095
0.5942 Remote Similarity NPC182428
0.5909 Remote Similarity NPC211594
0.5833 Remote Similarity NPC603782
0.5765 Remote Similarity NPC73511
0.5647 Remote Similarity NPC258035
0.5595 Remote Similarity NPC160515
0.5584 Remote Similarity NPC254741
0.5529 Remote Similarity NPC259070
0.5529 Remote Similarity NPC478528
0.5484 Remote Similarity NPC303913
0.5455 Remote Similarity NPC475261
0.5319 Remote Similarity NPC479405
0.5287 Remote Similarity NPC105511
0.5263 Remote Similarity NPC479404
0.5217 Remote Similarity NPC172807
0.5161 Remote Similarity NPC254540
0.5161 Remote Similarity NPC487212
0.5132 Remote Similarity NPC181124
0.5132 Remote Similarity NPC186507
0.5068 Remote Similarity NPC120924
0.5067 Remote Similarity NPC185607
0.5065 Remote Similarity NPC471590
0.5052 Remote Similarity NPC46202
0.5051 Remote Similarity NPC488089
0.5047 Remote Similarity NPC473895

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC510837 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.642 Remote Similarity NPD4381 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data